Xiangqian Su

25PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsSatellite communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 07, 2026
STK25 Inhibits Epithelial-Mesenchymal Transition and Metastasis via the TGF-β/SMAD2 Signaling Pathway in Colorectal Cancer.

|Apr 30, 2026
STK25 inhibits cancer-associated fibroblast activation to overcome cetuximab resistance in colorectal cancer.

|Feb 14, 2026
Amelioration of colorectal cancer-associated fibroblasts in immunosuppressive microenvironment by ferroptosis-based nanotherapy.

Shuren Wang, Zaozao Wang, Chenxin Wu

|Jul 29, 2025
STK25 Loss Augments Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Stability in Colorectal Cancer.

Xiaowen Qiao, Pu Xing, Hao Hao

|Jul 02, 2025
MTCH2 Deficiency Promotes E2F4/TFRC-Mediated Ferroptosis and Sensitizes Colorectal Cancer Liver Metastasis to Sorafenib.

Pu Xing, Jiangbo Chen, Hao Hao

|Jan 24, 2025
WFDC3 sensitizes colorectal cancer to chemotherapy by regulating ATM/ATR kinase signaling pathway.

Xinying Yang, Kai Weng, Pu Xing

Pageof 5

Frequent Collaborators

4 joint publications

Jiangbo Chen

4 joint publications

Beihai Jiang

3 joint publications

Tianqi Liu

3 joint publications

Pu Xing